Related Experiment Video
Updated: May 16, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis
M T Marrone1, V Venkataramanan, M Goodman
1Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30333, USA.
Surgery shows promise for treating drug-resistant tuberculosis (DR-TB). Meta-analyses indicate surgical interventions are linked to successful treatment outcomes in multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) patients.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Surgical Oncology
Background:
- The rise of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) necessitates re-evaluating treatment strategies.
- Surgical interventions are regaining consideration as a viable option for drug-resistant TB (DR-TB).
Purpose of the Study:
- To systematically review and assess the existing literature on the effectiveness of surgical interventions in treating drug-resistant TB.
- To synthesize evidence from comparative and single-arm studies on surgical outcomes in DR-TB patients.
Main Methods:
- Comprehensive literature search of Medline, EMBASE, and PubMed (1975-2012), supplemented by hand searching.
- Inclusion of studies comparing surgical and non-surgical treatments for MDR-TB and XDR-TB.
- Meta-analyses using random effects models to evaluate treatment outcomes based on internationally accepted definitions.
Main Results:
- Meta-analysis of 24 studies revealed a significant association between surgery and successful treatment of DR-TB (OR 2.24).
- 23 single-arm studies showed high rates of successful short-term (92%) and long-term (87%) outcomes in surgical patients.
- Favorable surgical outcomes correlated with increased drug resistance levels.
Conclusions:
- Surgical intervention appears associated with successful treatment outcomes in DR-TB.
- Insufficient evidence exists to recommend surgery over chemotherapy alone or to determine optimal surgical conditions.
- Further controlled studies are required to definitively assess surgical effectiveness and associated risks in DR-TB management.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
